DCGI

Mylan working with DCGI to launch new TB drug in India

Read more

AstraZeneca India receives marketing permission for QTERN

Read more

Zydus Cadila receives DCGI nod to market rabies drug in India

Read more

Punjab drug manufacturers call for urgent measures to curb corruption in CDSCO

Read more

Govt appoints VG Somani as new Drug Controller General

Read more

DCGI gives limited approval to market Stempeutics’ allogeneic cell therapy

Read more

DCG(I) bans 344 drugs constituting fixed dose combinations, but will it hold?

Read more

Indian scientists develop breakthrough dengue drug

Read more

Hetero receives DCG(I) approval for fixed-dose combination therapy ‘Ledipasvir-Sofosbuvir’

Read more

EU’s ban of 700 pharma products will impact Indian pharma export by $1 bn

Read more